Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb;25(1):29-36.
doi: 10.3109/09273948.2015.1094095. Epub 2016 Jan 4.

Ocular Behçet's Disease: Changing Patterns Over Time, Complications and Long-Term Visual Prognosis

Affiliations

Ocular Behçet's Disease: Changing Patterns Over Time, Complications and Long-Term Visual Prognosis

Massimo Accorinti et al. Ocul Immunol Inflamm. 2017 Feb.

Abstract

Purpose: To investigate demographic, clinical features and complications of Italian patients with ocular Behçet's disease (BD) over time.

Methods: Retrospective study of 385 patients examined from 1968 to 2011, 265 of whom had follow-up ≥ 12 months.

Results: A significant increase in the proportion of females (p = 0.03) and anterior uveitis (p < 0.001), and a decrease in the complete type of BD in all patients (p = 0.003) and in males (p = 0.002), and in hypopyon (p = 0.024) were observed over time. Optic neuropathy (p < 0.0001), maculopathy (p = 0.002), retinal detachment, and retinal neovascularization (p = 0.02) decreased over time, with no difference between genders, concomitant with an increase in the use of immunosuppressive drugs (p = 0.003). Visual acuity ≤1/10 was detected more often in males than females (p = 0.003).

Conclusions: A significant shift in clinical manifestations of BD patients was observed over 44 years. Immunosuppressive therapy succeeded in lowering ocular complications. The incidence of ocular BD is increasing in females, but visual prognosis is still worse in males.

Keywords: Behçet’s disease; complications; optic neuropathy; uveitis; visual prognosis.

PubMed Disclaimer

MeSH terms

Substances

LinkOut - more resources